|
| Analyst
Scorecard | | Analyst: | Aschoff, Jonathan | EPS
Est. Accuracy: | 
| | Broker: | Brean Murray, Carret & Co. | Recommendation
Performance: | Not Avl.
|
|
What is this?
This scorecard presents a summary of StarMine ratings
for this analyst.
Ratings are displayed when analysts score highly based
on the accuracy of
their earnings estimates or the returns of their stock
recommendations. Stocks
which appear on this scorecard are limited to those
covered by the analyst for
a significant period of time. Learn
More
|
| |
Industry Coverage
| | |
Industry
|
EPS Est. Accuracy
|
Industry Excess Return
|
Industry Return
| | | |
Biotechnology
| Not Avl.
| Not Avl.
| Not Avl.
| | | | |
Pharmaceuticals
| 
| Not Avl.
| Not Avl.
| | | |
| |
EPS Estimate Accuracy
| | |
Symbol
|
Company Name
|
EPS Est. Accuracy
|
No. Analysts
| | | |
ADLR
|
Adolor Corp
|
|
2
| | | | |
ALXN
|
Alexion Pharmaceuticals Inc
|
|
14
| | | | |
AUXL
|
Auxilium Pharmaceuticals Inc
|
|
15
| | | | |
BMRN
|
Biomarin Pharmaceutical Inc
|
|
18
| | | | |
CLDX
|
Celldex Therapeutics Inc
|
|
3
| | | | |
CYTR
|
Cytrx Corp
|
|
4
| | | | |
DNDN
|
Dendreon Corp
|
|
12
| | | | |
HALO
|
Halozyme Therapeutics Inc
|
|
7
| | | | |
HYTM.OB
|
Hythiam Inc
|
|
1
| | | | |
KERX
|
Keryx Biopharmaceuticals
|
|
2
| | | | |
MDVN
|
Medivation Inc
|
|
9
| | | | |
NKTR
|
Nektar Therapeutics
|
|
10
| | | | |
PGNX
|
Progenics Pharmaceuticals
|
|
4
| | | | |
SGMO
|
Sangamo Biosciences Inc
|
|
7
| | | | |
UTHR
|
United Therapeutics Corporation
|
|
17
| | | |
| Other Stocks Covered
| |
Cns Response Inc (CNSO.OB), Poniard Pharmaceuticals Inc (PARD), Pozen Inc (POZN), Ardea Biosciences Inc (RDEA)
|
| | |
|
|
|
